RITM Stock Analysis: Rithm Capital | NYSE
REIT - Mortgage | NYSE, USA | Market Cap: 5.154m USD | 12M Return: -8.2% | US64828T2015 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 59.3M
EPS Trend: 86.8%
Qual. Beats: 0
Rev. Trend: 90.2%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.9 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
Rithm Capital Corp. (NYSE: RITM) is a U.S.-based asset manager operating across real estate, credit, and financial services through three segments: Origination and Servicing, Residential Transitional Lending, and Asset Management and Investment Portfolio. Its investment portfolio spans single-family rental (SFR) properties, residential mortgage loans, real estate securities, excess mortgage servicing rights, servicer advance investments, collateralized loan obligations (CLOs), consumer loans, and title, appraisal, and property preservation services. The company also originates government-sponsored enterprise (GSE) and government-guaranteed loans, as well as non-GSE residential transitional loans.
Structured as a real estate investment trust (REIT), Rithm is generally exempt from federal corporate income tax provided it distributes at least 90% of its taxable income to shareholders-a feature common to REITs that typically results in higher dividend payouts but limits reinvestment flexibility. Originally incorporated in 2011 as New Residential Investment Corp., the company rebranded as Rithm Capital in August 2022, reflecting its evolution from a mortgage-focused REIT into a broader alternative asset manager. Its mid-cap valuation places it among mid-sized U.S. financial firms operating at the intersection of housing finance and asset management.
- Mortgage origination volume pressured by elevated interest rates
- MSR portfolio gains on interest rate volatility
- Asset management AUM expansion drives fee income growth
| Net Income: 504.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA 6.29 > 1.0 |
| NWC/Revenue: -269.3% < 20% (prev -32.47%; Δ -236.9% < -1%) |
| CFO/TA -0.03 > 3% & CFO -1.46b > Net Income 504.0m |
| Net Debt (40.0b) to EBITDA (2.10b): 19.04 < 3 |
| Current Ratio: 0.13 > 1.5 & < 3 |
| Outstanding Shares: last quarter (572.8m) vs 12m ago 3.90% < -2% |
| Gross Margin: 91.10% > 18% (prev 92.61%; Δ -1.51% > 0.5%) |
| Asset Turnover: 11.72% > 50% (prev 10.56%; Δ 1.16% > 0%) |
| Interest Coverage Ratio: 0.98 > 6 (EBIT TTM 1.78b / Interest Expense TTM 1.82b) |
| A: -0.29 (Total Current Assets 2.45b - Total Current Liabilities 18.8b) / Total Assets 56.7b |
| B: -0.00 (Retained Earnings -154.5m / Total Assets 56.7b) |
| C: 0.03 (EBIT TTM 1.78b / Avg Total Assets 51.9b) |
| D: 0.18 (Book Value of Equity 8.62b / Total Liabilities 47.1b) |
| Altman-Z'' = -1.48 = CCC |
| DSRI: 1.01 (Receivables 4.72b/3.83b, Revenue 6.08b/4.98b) |
| GMI: 1.02 (GM 92.61% / 91.10%) |
| AQI: 0.99 (AQ_t 0.95 / AQ_t-1 0.96) |
| SGI: 1.22 (Revenue 6.08b / 4.98b) |
| TATA: 0.03 (NI 504.0m - CFO -1.46b) / TA 56.7b) |
| Beneish M = -2.85 (Cap -4..+1) = A |
As of November 12, 2026, the stock is trading at USD 9.21 with a total of 4,754,163 shares traded. Over the past week, the price has changed by -3.05%, over one month by +8.10%, over three months by -7.56% and over the past year by -8.21%.
Current recommended Stop Loss: 8.70 (which is 5.5% or 1.9 ATR below the current price).
Rithm Capital has received a consensus analysts rating of 4.70. Therefore, it is recommended to buy RITM.
- StrongBuy: 7
- Buy: 3
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 12.8 | 39% |
P/E Trailing = 14.6508
P/E Forward = 4.0306
P/S = 1.0606
P/B = 0.7377
Revenue TTM = 6.08b USD
EBIT TTM = 1.78b USD
EBITDA TTM = 2.10b USD
Long Term Debt = 37.7b USD (from longTermDebt, last quarter)
Short Term Debt = 18.8b USD (from shortTermDebt, last quarter)
Debt = 42.4b USD (from shortLongTermDebtTotal, last quarter) + Leases 158.8m
Net Debt = 40.0b USD (calculated: Debt 42.4b - CCE 2.45b)
Enterprise Value = 45.1b USD (5.15b + Debt 42.4b - CCE 2.45b)
Interest Coverage Ratio = 0.98 (Ebit TTM 1.78b / Interest Expense TTM 1.82b)
EV/FCF = 1000.0x (Enterprise Value 45.1b / FCF TTM 37.0m)
FCF Yield = 0.08% (FCF TTM 37.0m / Enterprise Value 45.1b)
FCF Margin = 0.61% (FCF TTM 37.0m / Revenue TTM 6.08b)
Net Margin = 8.29% (Net Income TTM 504.0m / Revenue TTM 6.08b)
Gross Margin = 91.10% ((Revenue TTM 6.08b - Cost of Revenue TTM 541.2m) / Revenue TTM)
Gross Margin QoQ = none% (prev 63.81%)
Tobins Q-Ratio = 0.80 (Enterprise Value 45.1b / Total Assets 56.7b)
Interest Expense / Debt = 4.28% (Interest Expense 1.82b / Debt 42.4b)
Taxrate = 45.24% (437.3m / 966.5m)
NOPAT = 976.8m (EBIT 1.78b * (1 - 45.24%))
Current Ratio = 0.13 (Total Current Assets 2.45b / Total Current Liabilities 18.8b)
Debt / Equity = 4.92 (Debt 42.4b / totalStockholderEquity, last quarter 8.62b)
Debt / EBITDA = 19.04 (Net Debt 40.0b / EBITDA 2.10b)
Debt / FCF = 1.08k (out of range, set to none) (Net Debt 40.0b / FCF TTM 37.0m)
Total Stockholder Equity = 8.54b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.97% (Net Income 504.0m / Total Assets 56.7b)
RoE = 5.90% (Net Income TTM 504.0m / Total Stockholder Equity 8.54b)
RoCE = 3.86% (EBIT 1.78b / Capital Employed (Equity 8.54b + L.T.Debt 37.7b))
RoIC = 1.73% (NOPAT 976.8m / Invested Capital 56.4b)
WACC = 2.97% (E(5.15b)/V(47.6b) * Re(8.08%) + D(42.4b)/V(47.6b) * Rd(4.28%) * (1-Tc(0.45)))
Discount Rate = 8.08% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 96.47 | Cagr: 7.09%
[DCF] Terminal Value 75.44% ; FCFF base≈37.0m ; Y1≈37.2m ; Y5≈39.4m
[DCF] Fair Price = N/A (negative equity: EV 612.3m - Net Debt 40.0b = -39.3b; debt exceeds intrinsic value)
EPS Correlation: 86.85 | EPS CAGR: 6.30% | SUE: 0.63 | # QB: 0
Revenue Correlation: 90.18 | Revenue CAGR: 17.78% | SUE: 0.53 | # QB: 0
EPS current Quarter (2027-03-31): EPS=0.49 | Chg30d=+0.75% | Revisions=-17% | Analysts=10
EPS current Year (2026-12-31): EPS=2.32 | Chg30d=+0.96% | Revisions=+29% | GrowthEPS=-1.2% | GrowthRev=+33.5%
EPS next Year (2027-12-31): EPS=2.37 | Chg30d=+0.51% | Revisions=+0% | GrowthEPS=+1.8% | GrowthRev=+4.4%
[Analyst] Revisions Ratio: +6% (up=7, down=6)